Deslanoside

CAS No. 17598-65-1

Deslanoside( Deacetyllanatoside C | Desacetyllanatoside C )

Catalog No. M21488 CAS No. 17598-65-1

Deslanoside is a rapidly acting cardiac glycoside used to treat congestive heart failure and supraventricular arrhythmias due to reentry mechanisms. Deslanoside inhibits the Na-K-ATPase membrane pump resulting in an increase in intracellular sodium and calcium concentrations.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 256 In Stock
5MG 155 In Stock
10MG 246 In Stock
25MG 417 In Stock
50MG 586 In Stock
100MG 834 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Deslanoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Deslanoside is a rapidly acting cardiac glycoside used to treat congestive heart failure and supraventricular arrhythmias due to reentry mechanisms. Deslanoside inhibits the Na-K-ATPase membrane pump resulting in an increase in intracellular sodium and calcium concentrations.
  • Description
    Deslanoside is a rapidly acting cardiac glycoside used to treat congestive heart failure and supraventricular arrhythmias due to reentry mechanisms. Deslanoside inhibits the Na-K-ATPase membrane pump resulting in an increase in intracellular sodium and calcium concentrations.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Deacetyllanatoside C | Desacetyllanatoside C
  • Pathway
    Endocrinology/Hormones
  • Target
    ATPase
  • Recptor
    Na+/K+-ATPase
  • Research Area
    Cardiovascular Disease
  • Indication
    Congestive cardiac insufficiency arrhythmias and heart failure.

Chemical Information

  • CAS Number
    17598-65-1
  • Formula Weight
    943.1
  • Molecular Formula
    C47H74O19
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (106.04 mM)
  • SMILES
    C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2CC[C@]3([C@@H](C2)CC[C@@H]4[C@@H]3C[C@H]([C@]5([C@@]4(CC[C@@H]5C6=CC(=O)OC6)O)C)O)C)O)O[C@H]7C[C@@H]([C@@H]([C@H](O7)C)O[C@H]8C[C@@H]([C@@H]([C@H](O8)C)O[C@H]9[C@@H]([C@H]([C@@H]([C@H](O9)CO)O)O)O)O)O
  • Chemical Name
    4-((3S5R8R9S10S12R13S14S17R)-1214-dihydroxy-3-(((2R4S5S6R)-4-hydroxy-5-(((2S4S5S6R)-4-hydroxy-5-(((2S4S5S6R)-4-hydroxy-6-methyl-5-(((2S3R4S5S6R)-345-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-1013-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)furan-2(5H)-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hauptman PJ et al. Digitalis. Circulation. 1999 Mar 9;99(9):1265-70.
molnova catalog
related products
  • Paederosidic acid me...

    Paederosidic acid methyl ester has antinociception, is possibly related to the pathway of NO-cGMP-ATP sensitive K(+) channels.

  • Mtb ATP synthase-IN-...

    Mtb ATP synthase-IN-1 (compound 6ab) is a potent inhibitor of Mycobacterium tuberculosis (Mtb) ATP synthase (MIC = 0.452-0.499 μg/mL) that can be used in anti-mycobacterium research, showing low cytotoxicity (Vero IC 50 > 64 μg/mL) and acceptable oral bioavailability with good metabolic stability.

  • PF 03716556

    PF 3716556 is a potent and selective P-CAB (potassium-competitive acid blocker), with pIC50 of 6.026 and 7.095 for the inhibition of porcine H+,K+-ATPase activity in ion-leaky and ion-tight assay, respectively.